{
    "title": "Lilly's bowel disease drug gets US FDA nod for treatment in adults",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12678185/Lillys-bowel-disease-drug-gets-US-FDA-nod-treatment-adults.html",
    "date": "2023-10-26",
    "keywords": [
        "drug",
        "approval",
        "colitis",
        "inc",
        "johnson",
        "thursday",
        "health",
        "regulator",
        "type",
        "inflammatory",
        "bowel",
        "brand",
        "name",
        "omvoh",
        "growth",
        "decade",
        "obesity",
        "lebrikizumab",
        "atopic",
        "dermatitis",
        "eczema",
        "pirtobrutinib",
        "cancer",
        "decision",
        "sector",
        "abbvie",
        "pfizer",
        "amp",
        "share",
        "multibillion",
        "dollar",
        "market",
        "latestage",
        "disease",
        "placebo",
        "setback",
        "april",
        "food",
        "administration",
        "fda",
        "clearance",
        "manufacturing",
        "treatment",
        "japan",
        "union",
        "year",
        "condition",
        "immune",
        "system",
        "cause",
        "inflammation",
        "lining",
        "colon",
        "passing",
        "blood",
        "stool",
        "pain",
        "company",
        "trading",
        "reporting",
        "pratik",
        "jain",
        "khushi",
        "mandowara",
        "benagluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}